ENHANCED PROCESSING OF APP INDUCED BY IL-1-BETA CAN BE REDUCED BY INDOMETHACIN AND NORDIHYDROGUAIARETIC ACID

被引:36
作者
DASH, PK
MOORE, AN
机构
[1] Department of Neurobiology and Anatomy, University of Texas Health Science Center at Houston, Houston, TX 77225
关键词
D O I
10.1006/bbrc.1995.1372
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Abnormal processing of the amyloid precursor protein (APP) is thought to contribute to the formation of amyloid plaques in Alzheimer's disease. Several studies suggest that inflammation, and possibly the cytokines released during the inflammatory process, may participate in the plaque formation. We have utilized a cell culture system to examine the effects of the cytokine interleukin-1 beta (IL-1 beta) on the processing of APP. We present data to show that IL-1 beta increases the maturation of APP and causes enhanced processing of the full length APP isoforms. In addition, as reported previously in HUVEC cells, IL-1 beta increases the secretion of APP in PC12 cells. Indomethacin and NDGA, reported inhibitors of the cyclooxygenase and lipoxygenase pathways, respectively, block these effects,suggesting the involvement of prostaglandins and leukotrienes in IL-1 beta mediated APP processing. (C) 1995 Academic Press, Inc.
引用
收藏
页码:542 / 548
页数:7
相关论文
共 42 条
[1]   MEMBRANE DEPOLARIZATION AND CARBAMOYLCHOLINE STIMULATE PHOSPHATIDYLINOSITOL TURNOVER IN INTACT NERVE-TERMINALS [J].
AUDIGIER, SMP ;
WANG, JKT ;
GREENGARD, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (08) :2859-2863
[2]  
BHAUNIK S, 1991, J MENTL DEFIC RES, V35, P521
[3]   CLINICAL GENETICS AND GENETIC-COUNSELING IN ALZHEIMER-DISEASE [J].
BREITNER, JCS .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (08) :601-606
[4]   INVERSE ASSOCIATION OF ANTIINFLAMMATORY TREATMENTS AND ALZHEIMERS-DISEASE - INITIAL RESULTS OF A COTWIN CONTROL STUDY [J].
BREITNER, JCS ;
GAU, BA ;
WELSH, KA ;
PLASSMAN, BL ;
MCDONALD, WM ;
HELMS, MJ ;
ANTHONY, JC .
NEUROLOGY, 1994, 44 (02) :227-232
[5]   PROCESSING OF ALZHEIMER BETA-A4 AMYLOID PRECURSOR PROTEIN - MODULATION BY AGENTS THAT REGULATE PROTEIN-PHOSPHORYLATION [J].
BUXBAUM, JD ;
GANDY, SE ;
CICCHETTI, P ;
EHRLICH, ME ;
CZERNIK, AJ ;
FRACASSO, RP ;
RAMABHADRAN, TV ;
UNTERBECK, AJ ;
GREENGARD, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (15) :6003-6006
[6]   CHOLINERGIC AGONISTS AND INTERLEUKIN-1 REGULATE PROCESSING AND SECRETION OF THE ALZHEIMER BETA/A4 AMYLOID PROTEIN-PRECURSOR [J].
BUXBAUM, JD ;
OISHI, M ;
CHEN, HI ;
PINKASKRAMARSKI, R ;
JAFFE, EA ;
GANDY, SE ;
GREENGARD, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10075-10078
[7]   CHLOROQUINE INHIBITS INTRACELLULAR DEGRADATION BUT NOT SECRETION OF ALZHEIMER BETA/A4 AMYLOID PRECURSOR PROTEIN [J].
CAPORASO, GL ;
GANDY, SE ;
BUXBAUM, JD ;
GREENGARD, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (06) :2252-2256
[8]   INHIBITORS OF ENDOCYTOSIS, ENDOSOME FUSION, AND LYSOSOMAL PROCESSING INHIBIT THE INTRACELLULAR PROTEOLYSIS OF THE AMYLOID PRECURSOR PROTEIN [J].
DASH, PK ;
MOORE, AN .
NEUROSCIENCE LETTERS, 1993, 164 (1-2) :183-186
[9]   NOVEL THERAPY FOR ALZHEIMERS-DISEASE [J].
DEFEUDIS, FV .
NEUROBIOLOGY OF AGING, 1989, 10 (05) :467-468
[10]   INTERLEUKIN-1 AND ITS BIOLOGICALLY RELATED CYTOKINES [J].
DINARELLO, CA .
ADVANCES IN IMMUNOLOGY, 1989, 44 :153-205